Virginia Commonwealth University (VCU) is a clinical research site located in Richmond, Virginia, United States 23219.
Crixeo Clinical Trials Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.
Virginia Commonwealth University (VCU) has participated in 12 clinical trials with 8 currently active.
Therapeutic areas: Sickle Cell Disease, Aortic Aneurysm, Abdominal, Myotonic Dystrophy Type 1 (DM1).
Sponsors: Genetix Biotherapeutics Inc., Rijnstate Hospital, Dyne Therapeutics.
Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Virginia Commonwealth University (VCU) has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Virginia Commonwealth University (VCU) has 12 clinical trials on record, with 8 currently active. Their work covers Sickle Cell Disease, Aortic Aneurysm, Abdominal, Myotonic Dystrophy Type 1 (DM1).
Virginia Commonwealth University (VCU) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.